Organon & Co. (NYSE: OGN) Announces Departure of Chief Commercial Officer Organon & Co., a Delaware corporation with its principal executive offices in Jersey City, New Jersey, recently filed an 8-K report with the Securities and Exchange Commission

This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Organon & Co.’s 8K filing here. About Organon & Co. (Get Free Report) Organon & Co is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a […]

Leave a Reply

Your email address will not be published.

Previous post Fifth Third Bancorp Increases Stock Position in Paycor HCM, Inc. (NASDAQ:PYCR)
Next post Today in History: January 27, Auschwitz and Birkenau concentration camps liberated by Soviet troops